500
Participants
Start Date
March 20, 2023
Primary Completion Date
March 31, 2033
Study Completion Date
March 31, 2033
No intervention
No intervention
RECRUITING
Ascendis Investigational Site, New Hyde Park
RECRUITING
Ascendis Investigational Site, Washington D.C.
RECRUITING
Ascendis Investigational Site, Norfolk
RECRUITING
Ascendis Investigational Site, Columbia
RECRUITING
Ascendis Investigational Site, Sandy Springs
RECRUITING
Ascendis Investigational Site, Orlando
RECRUITING
Ascendis Investigational Site, Orlando
RECRUITING
Ascendis Investigational Site, Tampa
RECRUITING
Ascendis Investigational Site, Louisville
RECRUITING
Ascendis Investigational Site, Indianapolis
RECRUITING
Ascendis Investigational Site, Iowa City
RECRUITING
Ascendis Investigational Site, Minneapolis
RECRUITING
Ascendis Investigational Site, El Paso
RECRUITING
Ascendis Pharma Investigational Site, Centennial
RECRUITING
Ascendis Investigational Site, Boise
RECRUITING
Ascendis Investigational Site, Phoenix
RECRUITING
Ascendis Investigational Site, Las Vegas
RECRUITING
Ascendis Investigational Site, San Francisco
RECRUITING
Ascendis Investigational Site, Sacramento
RECRUITING
Ascendis Investigational Site, Portland
RECRUITING
Ascendis Investigational Site, Seattle
RECRUITING
Ascendis Investigational Site, Lebanon
RECRUITING
Ascendis Investigational Site, Morristown
Ascendis Pharma Endocrinology Division A/S
INDUSTRY